Results Healthcare   |   Results International

CROs and CMOs

We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

CROs and CMOs

Clinical/contract research organisations (CROs) in particular are among the strongest growth sectors of the pharmaceutical industry, with many firms across the sector experiencing double- digit annual growth. This growth is driven by the trend for increased outsourcing by pharmaceutical and biotechnology companies looking to shift fixed to variable costs and access specialist capabilities not found in-house, and an overall increase in biopharmaceutical R&D spending. CROs have also become one of the most active sectors for M&A, with larger players consolidating to achieve critical mass, as well as completing bolt-on acquisitions to offer a more comprehensive service offering.

Our team has a strong track-record in successful CRO transactions.

10 Apr 2019

Why the rare disease clinical trials space is so attractive to CROs: M&A activity

Addressing unmet therapeutic areas in rare diseases is just one rapidly expanding area in clinical research. Pharma is consistently looking…

19 Mar 2019

CRO Sector M&A drivers and market trends

Contract Research Organisations (CROs) typically provide discovery and development services to the pharmaceutical, biotechnology and medical devices industries (frequently referred…

Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:

23 Jun 2019 - 09.00am-6.00pm

DIA 2019 Global Annual Meeting

DIA’s Global Annual Meeting (DIA 2019) gathers stakeholders from across the world to openly knowledge share, generating insights beyond boundaries…

Insights

Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office